Silvia Paredes1,2, Marta Alves3, Maria Lopes Pereira3, Olinda Marques3, Laura Ribeiro4,5. 1. Endocrinology Department, Hospital de Braga, Sete Fontes, São Victor, 4710-243, Braga, Portugal. silvia.sparedes@gmail.com. 2. Department of Public Health and Forensic Sciences, and Medical Education, Medical Education Unit, Faculty of Medicine of the University of Porto, 4200-319, Porto, Portugal. silvia.sparedes@gmail.com. 3. Endocrinology Department, Hospital de Braga, Sete Fontes, São Victor, 4710-243, Braga, Portugal. 4. Department of Public Health and Forensic Sciences, and Medical Education, Medical Education Unit, Faculty of Medicine of the University of Porto, 4200-319, Porto, Portugal. 5. I3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-319, Porto, Portugal.
Abstract
BACKGROUND: Patients with metabolic syndrome (MetS) are at high risk of developing cardiovascular disease (CVD) and lipoprotein(a) (Lp(a)) is an independent risk factor for CVD. This study aimed to determine the effect of vertical sleeve gastrectomy (VSG)-induced weight loss on Lp(a) levels in obese individuals. METHODS: Patients submitted to VSG from January 2011 to July 2015 were included. Anthropometric and metabolic parameters were recorded before and 12 months after surgery. Univariate analysis identified associations between Lp(a) and anthropometry and metabolic parameters, and the logistic regression predictors of Lp(a) decrease after VSG. RESULTS: MetS was present in 47% of the 330 patients involved. Patients with MetS had higher body mass index (BMI) and triglyceride levels and were more insulin-resistant. No differences were found between groups respecting Lp(a) levels prior to surgery (15.2 mg/dL vs. 15.0 mg/dL, p = 0.795). After surgery, patients without MetS had a decrease in Lp(a) levels (14.7 mg/dL vs. 12.3 mg/dL, p = 0.006), while MetS patients showed no differences (13.9 mg/dL vs. 14.6 mg/dL, p = 0.302). The regression model evidenced that older age and Δ HDL-c were predictors of Lp(a) decrease, whereas the greater the number of MetS components and lower estimated BF% loss, the lesser odds of decreasing Lp(a) after surgery. CONCLUSIONS: Despite a global improvement of conventional CVD risk factors, only individuals without MetS showed a decrease of Lp(a) levels after VSG. Further studies should explore not only the pathophysiological mechanisms underlying the absence of decrease of Lp(a) levels in MetS patients, but also its impact on the metabolic beneficial changes usually observed after VSG.
BACKGROUND:Patients with metabolic syndrome (MetS) are at high risk of developing cardiovascular disease (CVD) and lipoprotein(a) (Lp(a)) is an independent risk factor for CVD. This study aimed to determine the effect of vertical sleeve gastrectomy (VSG)-induced weight loss on Lp(a) levels in obese individuals. METHODS:Patients submitted to VSG from January 2011 to July 2015 were included. Anthropometric and metabolic parameters were recorded before and 12 months after surgery. Univariate analysis identified associations between Lp(a) and anthropometry and metabolic parameters, and the logistic regression predictors of Lp(a) decrease after VSG. RESULTS:MetS was present in 47% of the 330 patients involved. Patients with MetS had higher body mass index (BMI) and triglyceride levels and were more insulin-resistant. No differences were found between groups respecting Lp(a) levels prior to surgery (15.2 mg/dL vs. 15.0 mg/dL, p = 0.795). After surgery, patients without MetS had a decrease in Lp(a) levels (14.7 mg/dL vs. 12.3 mg/dL, p = 0.006), while MetSpatients showed no differences (13.9 mg/dL vs. 14.6 mg/dL, p = 0.302). The regression model evidenced that older age and Δ HDL-c were predictors of Lp(a) decrease, whereas the greater the number of MetS components and lower estimated BF% loss, the lesser odds of decreasing Lp(a) after surgery. CONCLUSIONS: Despite a global improvement of conventional CVD risk factors, only individuals without MetS showed a decrease of Lp(a) levels after VSG. Further studies should explore not only the pathophysiological mechanisms underlying the absence of decrease of Lp(a) levels in MetSpatients, but also its impact on the metabolic beneficial changes usually observed after VSG.
Authors: D N Kiortsis; T Tzotzas; P Giral; E Bruckert; I Beucler; S Valsamides; G Turpin Journal: Nutr Metab Cardiovasc Dis Date: 2001-06 Impact factor: 4.222
Authors: André J Tremblay; Hugo Morrissette; Jean-Marc Gagné; Jean Bergeron; Claude Gagné; Patrick Couture Journal: Clin Biochem Date: 2004-09 Impact factor: 3.281
Authors: M Garciacaballero; A Reyes-Ortiz; M García; J M Martínez-Moreno; J A Toval; A García; A Mínguez; D Osorio; J M Mata; F Miralles Journal: Obes Surg Date: 2014-12 Impact factor: 4.129
Authors: Indumathi Chennamsetty; Thierry Claudel; Karam M Kostner; Michael Trauner; Gert M Kostner Journal: Arterioscler Thromb Vasc Biol Date: 2012-01-19 Impact factor: 8.311
Authors: Richard J Wood; Jeff S Volek; Steven R Davis; Carly Dell'Ova; Maria Luz Fernandez Journal: Nutr Metab (Lond) Date: 2006-05-04 Impact factor: 4.169
Authors: Christoph Waldeyer; Nataliya Makarova; Tanja Zeller; Renate B Schnabel; Fabian J Brunner; Torben Jørgensen; Allan Linneberg; Teemu Niiranen; Veikko Salomaa; Pekka Jousilahti; John Yarnell; Marco M Ferrario; Giovanni Veronesi; Paolo Brambilla; Stefano G Signorini; Licia Iacoviello; Simona Costanzo; Simona Giampaoli; Luigi Palmieri; Christa Meisinger; Barbara Thorand; Frank Kee; Wolfgang Koenig; Francisco Ojeda; Jukka Kontto; Ulf Landmesser; Kari Kuulasmaa; Stefan Blankenberg Journal: Eur Heart J Date: 2017-08-21 Impact factor: 29.983
Authors: Veronica Davila-Batista; Antonio J Molina; Laura Vilorio-Marqués; Leila Lujan-Barroso; Fernanda de Souza-Teixeira; Rocío Olmedo-Requena; Jorge Arias de la Torre; Lidia García-Martínez; Laura Álvarez-Álvarez; Heinz Freisling; Javier Llorca; Miguel Delgado-Rodríguez; Vicente Martin Journal: Eur J Nutr Date: 2018-06-11 Impact factor: 5.614